Metixene is an anticholinergic antiparkinsonian agent, potently inhibits the binding of quinuclidinyl to the muscarinic receptor in rat brain cortical tissue (IC50: 55 nM, Kd: 15 nM) [1].

7081-40-5

C20H26ClNOS

363.95

DMSO:85 mg/mL (233.55 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years